These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cervical cancer screening data from two cohorts in British Columbia. van Oortmarssen GJ; Habbema JD IARC Sci Publ; 1986; (76):47-60. PubMed ID: 3570415 [No Abstract] [Full Text] [Related]
3. Lifelong protection from cervical cancer. Cadman L Community Nurse; 1998 Jan; 3(12):12-3. PubMed ID: 9505588 [No Abstract] [Full Text] [Related]
4. [Cervical cancer screening]. Delaloye JF; De Grandi P Rev Med Suisse Romande; 1997 Aug; 117(8):589-91. PubMed ID: 9340712 [No Abstract] [Full Text] [Related]
5. Cervical cytology 1980 -- its place and value. Duncan GR N Z Med J; 1981 Feb; 93(678):119-22. PubMed ID: 6943454 [No Abstract] [Full Text] [Related]
6. Results from a cervical cancer screening programme in Manitoba, Canada. Choi NW; Nelson NA IARC Sci Publ; 1986; (76):61-7. PubMed ID: 3570416 [No Abstract] [Full Text] [Related]
7. Effect of a mass screening program on the risk of cervical cancer. Louhivuori K Cancer Detect Prev; 1991; 15(6):471-5. PubMed ID: 1782637 [TBL] [Abstract][Full Text] [Related]
8. Time trends in cervical cancer screening rates in the OECD countries. Machii R; Saito H Jpn J Clin Oncol; 2011 May; 41(5):731-2. PubMed ID: 21536695 [No Abstract] [Full Text] [Related]
9. Cytological mass screening in Ostfold County, Norway. Magnus K; Langmark F IARC Sci Publ; 1986; (76):87-90. PubMed ID: 3570418 [No Abstract] [Full Text] [Related]
10. Effect of cervical cancer screening in Scandinavia. Day NE Obstet Gynecol; 1984 May; 63(5):714-8. PubMed ID: 6717876 [TBL] [Abstract][Full Text] [Related]
11. Further discussion on the role of pap smear screening. Littell JT Am Fam Physician; 2000 Nov; 62(10):2232, 2235. PubMed ID: 11126851 [No Abstract] [Full Text] [Related]
12. At what age should cervical screening stop? Strander B BMJ; 2009 Apr; 338():b809. PubMed ID: 19395422 [No Abstract] [Full Text] [Related]
13. [Exclusion of low-risk women from screening programs for cervix uteri cancers: based on mathematical modeling]. Arveux P Rev Epidemiol Sante Publique; 1999 Sep; 47(4):389-90. PubMed ID: 10519180 [No Abstract] [Full Text] [Related]
14. Evaluation of the impact of screening for cancer of the cervix. Miller AB IARC Sci Publ; 1986; (76):149-60. PubMed ID: 3570400 [No Abstract] [Full Text] [Related]
15. Letter: Who should be screened for cervical cancer? N Engl J Med; 1976 May; 294(19):1064-5. PubMed ID: 1256517 [No Abstract] [Full Text] [Related]
16. [Mass screening for early-stage cancer of the uterine cervix]. Gunbjørud AB; Stenling CA Tidsskr Nor Laegeforen; 1991 Oct; 111(25):3053-4. PubMed ID: 1948913 [No Abstract] [Full Text] [Related]
17. Cervical cancer screening and the role of the physician. Schultz R J Med Assoc Ga; 1994 Apr; 83(4):199-200. PubMed ID: 8006545 [No Abstract] [Full Text] [Related]
18. Mortality from cervical cancer: can it be prevented now? Kessler II Compr Ther; 1976 Sep; 2(9):38-47. PubMed ID: 963967 [No Abstract] [Full Text] [Related]
19. High risk groups and screening for cancer. Jensen OM Cancer Detect Prev; 1982; 5(3):343-8. PubMed ID: 7151068 [TBL] [Abstract][Full Text] [Related]
20. The epidemiological basis for evaluating different screening policies. Day NE IARC Sci Publ; 1986; (76):199-212. PubMed ID: 3570405 [No Abstract] [Full Text] [Related] [Next] [New Search]